Carcinoma, Non-Small-Cell Lung Clinical Trials

Active, Not Recruiting

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

NCT06003231

Conditions: Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +24 more
Locations: Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States

Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Gilbert, Arizona, United States

Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Glendale, Arizona, United States

Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Mesa, Arizona, United States

View all 96 locations

View Trial Details

Active, Not Recruiting

Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation

NCT03833154

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Research Site Tuscaloosa, Alabama, United States

Research Site Chandler, Arizona, United States

Research Site Phoenix, Arizona, United States

Research Site Tucson, Arizona, United States

View all 209 locations

View Trial Details

Active, Not Recruiting

A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer

NCT03456076

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Rush University Medical Center Chicago, Illinois, United States

MGH Cancer Center Boston, Massachusetts, United States

AHN Cancer Institute ? Allegheny General Hospital Pittsburgh, Pennsylvania, United States

Chris O'Brien Lifehouse Camperdown, New South Wales, Australia

View all 114 locations

View Trial Details

Active, Not Recruiting

Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study

NCT03381274

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Research Site La Jolla, California, United States

Research Site San Francisco, California, United States

Research Site Aurora, Colorado, United States

Research Site New Haven, Connecticut, United States

View all 13 locations

View Trial Details

Active, Not Recruiting

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

NCT06120140

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Ironwood Cancer and Research Center Chandler, Arizona, United States

City of Hope Duarte, California, United States

Providence Fullerton Fullerton, California, United States

Los Angeles Cancer Network Glendale, California, United States

View all 93 locations

View Trial Details

Active, Not Recruiting

A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer

NCT05908734

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: City of Hope Duarte, California, United States

City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States

Cancer and Blood Specialty Clinic Los Alamitos, California, United States

Providence Portland Medical Center Portland, Oregon, United States

View all 44 locations

View Trial Details

Active, Not Recruiting

A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT04487080

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Arizona Oncology Associates, PC - HAL Goodyear, Arizona, United States

Yuma Regional Medical Center Yuma, Arizona, United States

City of Hope Long Beach Elm Long Beach, California, United States

University of California Irvine Orange, California, United States

View all 269 locations

View Trial Details

Active, Not Recruiting

A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions

NCT04538664

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: City of Hope 2 Duarte, California, United States

University of California Irvine Orange, California, United States

UCLA Santa Monica, California, United States

Georgetown University Hospital Washington D.C., District of Columbia, United States

View all 232 locations

View Trial Details

Active, Not Recruiting

A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer

NCT04077463

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

University of California Irvine Orange, California, United States

UCSF Helen Diller Comprehensive San Francisco, California, United States

Stanford University Medical Center Stanford, California, United States

View all 78 locations

View Trial Details

Active, Not Recruiting

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

NCT05663866

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Compassionate Cancer Care Fountain Valley, California, United States

Virginia Cancer Specialists Fairfax, Virginia, United States

UW Medicine Valley Medical Center Renton, Washington, United States

CHU de Brest - Hopital de la Cavale Blanche Brest, France

View all 36 locations

View Trial Details

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung trial results

Related conditions